Genes, environment and immunity in the development of rheumatoid arthritis
Introduction
Rheumatoid arthritis (RA) is a disease that is mainly defined by its clinical features, notably chronic inflammation in several joints associated with a characteristic destruction of bone and cartilage. Several different diagnostic criteria have been used to define the disease; the most recent ones were described by a group appointed by the American College of Rheumatology in 1988 [1]. However, no common etiological or pathogenetic features exist that a priori characterize rheumatoid arthritis, and any effort to define putative etiologies and pathogenic pathways has to consider the likelihood that several etiologies and several pathogenic pathways are in action in different subsets of RA.
In this review, we will use data on environmental triggers, genetics and specific immunity as major determinants in our efforts to define subsets of RA that might involve different etiological pathways. By applying such a subset-oriented approach to RA pathogenesis, we might begin to understand how triggers, genes and immunity interact, as has been possible for various well-defined animal models of arthritis.
Section snippets
Genes
To date, genes important for the onset or course of RA have been described mainly by the association of variations in genes coding for proteins that participate in known immune and/or inflammatory events of putative importance for joint inflammation. The genes for the MHC class II transplantation antigens were described as susceptibility genes in the 1970s [2], and subsequent studies have detailed which genes and which structures within these genes, in particular the so-called shared epitope
Environment
Information on environmental factors important for the development or course of RA is surprisingly scarce. Smoking is the only conventional environmental factor that has reproducibly been linked to an increased risk of developing RA [9, 10, 11], whereas other exposures such as silica dust and mineral oil exposures have been reported in a few studies [12, 13, 14, 15]. Frequently hypothesized stimuli such as microbial infections have not been possible to verify with the methods used to date.
Immunity
Studies on specific immune reactions in RA have been almost entirely confined to those involving autoantibodies; the knowledge of T-cell reactivates of importance for disease is very limited. The rheumatoid factor (RF) described in the late-1930s was, until recently, the most significant reactivity associated with RA and this reactivity was used in the RA classification criteria [1]. The formation of RF is, however, a feature of many immune reactions involving immune complex formation [18, 19].
Genes, environment and immunity considered together
Until now, the roles of genes, environment and immunity as etiological factors for RA have mainly been studied separately. Developing a greater understanding of RA etiologies requires, however, knowledge on how different risk factors, including genes and environment, interact in different subsets of RA. To contribute to such knowledge, we started, ten years ago, a Swedish population-based case control study on incident cases of RA and controls (matched for sex, age and location). We collected
Interactions between smoking, HLA-DRB1 SE alleles and anti-CP immunity
To investigate gene–environment interactions in major subsets of RA, we first considered smoking as the best-known environmental risk factor along with the presence of HLA-DRB1 SE alleles as the best-known genetic risk factor. Our aim was to correlate these factors with the occurrence of the two major serologically defined dichotomous subsets of RA that affect disease course, the RF+/RF− and anti-CP+/anti-CP− subsets.
The first experiment using this approach for RF, published in 2004 [33],
Biological interpretations of data from studying gene–environment–immunity interactions in different subsets of RA
The most interesting consequence of the new studies on the interactions between genes, environment and immunity in RA relates to the possible biological basis of the findings, and whether the findings from genetic epidemiology can help to develop a better molecular understanding of the chain of events that ultimately leads to arthritis in discrete subsets of RA patients.
The finding of smoking–HLA-DRB1 SE interactions in the anti-CP+ subset of disease led to the question of whether smoking can
Conclusions
The data summarised in this review indicate that detailed studies on interactions between genes, environment and immunity in large prospective studies of a disease — here RA — might provide us with new hypotheses on molecular pathways leading to the disease. The obvious aim of this research is to investigate these hypotheses via functional studies in subgroups of RA patients defined by their genes, their antibody profiles and their background environmental exposures. Only by using this
References and recommended reading
Papers of particular interest, published within the annual period of review, have been highlighted as:
• of special interest
•• of outstanding interest
Acknowledgements
We primarily acknowledge the Epidemiological Investigation of Risk Factors for RA (EIRA) study group, without which the Swedish case-control study would not have been possible. The members of the EIRA group are listed in [37••]. Studies from our own group that have been referred to here were financially supported by the Swedish Research Council, Söderbergs Foundations, the EU (the AUTOCURE consortium), King Gustaf V:s 80-year Foundation, the Swedish Rheumatism Foundation, the Swedish Council
References (50)
- et al.
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4
Am J Hum Genet
(2005) - et al.
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis
Am J Hum Genet
(2004) - et al.
Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor α, interleukin-1β, and interleukin-8 from peripheral blood monocytes via fcγ receptor IIA: A potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis
Arthritis Rheum
(2006) - et al.
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies
J Clin Invest
(1998) - et al.
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
Arthritis Rheum
(1988) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis
N Engl J Med
(1978)- et al.
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
Arthritis Rheum
(1987) - et al.
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction
Nat Genet
(2005) - et al.
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
Nat Genet
(2003) - et al.
Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis
Ann Rheum Dis
(2005)
Cigarette smoking increases the risk of rheumatoid arthritis: results from a nationwide study of disease-discordant twins
Arthritis Rheum
A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals
Arthritis Rheum
Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases
Ann Rheum Dis
Silica exposure and Rheumatoid arthritis: a follow up study of granite workers 1940–81
Br Med J
Rheumatoid arthritis in workers exposed to silica in the pottery industry
Occup Environ Med
Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study
Ann Rheum Dis
Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study
Arthritis Res Ther
Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives
Arthritis Rheum
Female hormone therapy and the risk of developing or exacerbating systemic lupus erythematosus or rheumatoid arthritis
Proc Assoc Am Physicians
Rheumatoid factor (RF) production during anamnestic immune responses in the mouse. III. Activation of RF precursor cells is induced by their interaction with immune complexes and carrier-specific helper T cells
J Exp Med
Rheumatoid factor revisited
Curr Opin Rheumatol
Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis
Arthritis Rheum
Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody
Mayo Clin Proc
The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease
Adv Immunol
The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide
Arthritis Rheum
Cited by (142)
Immuno-modulating theranostic gold nanocages for the treatment of rheumatoid arthritis in vivo
2022, Chemical Engineering JournalAssessment of serum interleukin-20 level in rheumatoid arthritis patients: Relation to disease activity and ultrasound measures
2022, Egyptian RheumatologistCitation Excerpt :Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovitis and synovial membrane hypertrophy resulting in pannus formation which eventually causes joint damage and physical disability [1]. The exact pathogenesis of RA is not clearly identified; however, environmental and genetic factors, as well as uncontrolled immune response have been implicated [2]. Numerous cytokines and chemokines secreted by innate immune cells are directly concerned with the inflammatory processes that are associated with RA development [3].
The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial
2021, International ImmunopharmacologyCitation Excerpt :Rheumatoid arthritis (RA) is a chronic auto-inflammatory disorder that highly contributes to global morbidity and mortality [1]. The complex cross talk between environment, genetics, and immunological response plays a crucial role in the pathogenesis of RA [2]. Current treatment strategies comprise conventional disease-modifying anti-rheumatic drugs (DMARDs), and if it is necessary to achieve low disease activity or remission, the biological DMARDs could be used afterward [3].
Innate immunity drives pathogenesis of rheumatoid arthritis
2021, Biomedical JournalThe relationship between fish consumption and rheumatoid arthritis; a systematic review and meta-analysis
2024, Immunopathologia Persa